ABBV Jan 2024 140.000 put
- PR Newswire
Experience the JUVÉDERM® Difference with Allergan Aesthetics
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), invites consumers to experience the JUVÉDERM® difference. The JUVÉDERM® Collection of Fillers is the number one selling collection of dermal fillers on the market and offers the largest portfolio of fillers specifically designed for different areas of the face to address key patient concerns, enabling a customized treatment approach.1 Injectable dermal fillers are highly sought-after treatments among consumers who are looking to address key si
- Zacks
Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA
Roche's (RHHBY) sBLA seeking approval for the use of Polivy in combination with R-CHP for previously untreated diffuse large B-cell lymphoma in adults has been accepted in the United States.
- Zacks
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
